2023-08-08 08:32:44 ET
- Processa Pharmaceuticals ( NASDAQ: PCSA ) has announced that industry veteran George Ng has been appointed to serve as the Company’s CEO and as a Board Director as of August 8, 2023.
- Dr. David Young will focus his efforts on the development of the Next Generation Chemotherapy drugs as President of Research and Development and as a board member.
- Mr. Ng is a seasoned life sciences industry executive who joins Processa from his previous position as Board Director, President, and COO at Calidi Biotherapeutics.
For further details see:
Processa Pharmaceuticals appoints Ng as CEO